Insider trades

Orbimed Advisors, Director of ADARx Pharmaceuticals ADRX, has filed 64 purchases and 182 sales on the open market. Over the past 12 months that comes to a net sale of $30.8M. The latest trade was on 09/28.

Orbimed Advisors

Director
First filing
23/01/03
Trades
362 trades
Buys / sales
64 / 182
12-month net buying
−$30.8M
Last trade
09/28

Trading activity

Transactions

Trade type
ADRX
Open-market buy09/2809/30950,000 sh3 trades$17.00avg.$16,150,000No record
ETRA
Open-market buy09/2109/231,333,333 sh2 trades$15.00avg.$19,999,995+313.8%
ELVN
Open-market sale06/2206/24860,123 sh4 trades$45.36avg.$39,014,045.6−11.6%
ELVN
Open-market sale06/1506/17281,408 sh2 trades$45.02avg.$12,668,988.16−3.7%
QTTB
Open-market buy05/2806/011,875,000 sh2 trades$8.00avg.$15,000,000No record
Open-market sale10b5-1 plan05/2705/29101 sh$44.49$4,493.49−0.0%
SION
Open-market sale10b5-1 plan05/07–05/1105/11292,952 sh3 trades$45.62avg.$13,364,064.5−9.9%
Open-market buy04/1604/28597,729 sh$1.67$998,207.43+98.7%
PRLD
Open-market buy04/2104/232,815,315 sh2 trades$4.44avg.$12,499,998.6No record
SION
Open-market sale10b5-1 plan04/17–04/1804/2155,345 sh2 trades$44.67avg.$2,472,342.92−1.8%
SION
Open-market sale10b5-1 plan04/14–04/1604/16510,583 sh3 trades$44.94avg.$22,945,043.5−14.5%
ACET
Open-market sale04/07–04/0804/09104,658 sh4 trades$6.45avg.$674,847.06−100.0%
SION
Open-market sale10b5-1 plan02/02–02/0302/0430,953 sh2 trades$44.58avg.$1,379,865.84−0.9%
Open-market sale10b5-1 plan25/12/2425/12/2933,356 sh$44.55$1,486,009.8−0.9%
SION
Open-market sale10b5-1 plan25/12/17–25/12/1925/12/191,875 sh3 trades$44.49avg.$83,427.75−0.1%
SION
Open-market sale10b5-1 plan25/11/24–25/11/2625/11/26108,073 sh3 trades$44.55avg.$4,814,204.82−2.9%
Open-market sale25/10/2325/10/271,000,000 sh$1.52$1,520,000−16.7%
ACET
Open-market buy25/10/0825/10/105,000,000 sh2 trades$1.00avg.$5,000,000No record
Open-market sale25/09/1025/09/12500,000 sh$1.80$900,000−7.7%
STTK
Open-market buy25/08/2525/09/026,306,127 sh2 trades$0.87avg.$5,486,330.49No record